Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALONZO E JONES

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1952389991
CMS profile
418907
Location
COLUMBUS, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$570.20

38 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $570.20 38

By paying entity

PY2021 · entire year · sorted by reported total

Page 1 of 1; records 1–38 of 38 matching records. This page contains 38 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALONZO E JONES

NPI 1952389991 · CMS profile ID 418907

Allopathic & Osteopathic Physicians / Internal Medicine / Cardiovascular Disease

COLUMBUS, GA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–38 of 38 matching records. This page contains 38 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1952389991?year=2021&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALONZO E JONES, NPI 1952389991, CMS profile ID 418907. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–38 of 38 matching records. This page contains 38 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1952389991?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). ALONZO E JONES, NPI 1952389991, CMS profile ID 418907. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–38 of 38 matching records. This page contains 38 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1952389991?year=2021&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
ALONZO E JONES, NPI 1952389991, CMS profile ID 418907, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–38 of 38 matching records. This page contains 38 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1952389991?year=2021&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

38 matching records · $570.20 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 38 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–38 of 38.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $7.8412/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735309 CMS
Medtronic, Inc. $18.2708/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827277997 CMS
Novartis Pharmaceuticals Corporation $13.6608/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735307 CMS
Bayer HealthCare Pharmaceuticals Inc. $13.2007/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789095881 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $13.9207/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 768813200 CMS
Esperion Therapeutics, Inc. $14.4907/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838321819 CMS
Janssen Pharmaceuticals, Inc $11.6407/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788855849 CMS
Medtronic, Inc. $20.1907/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827277989 CMS
Novartis Pharmaceuticals Corporation $17.8507/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735305 CMS
Medtronic, Inc. $19.7706/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827277995 CMS
AstraZeneca Pharmaceuticals LP $13.0506/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829703455 CMS
Lantheus Medical Imaging, Inc. $20.1106/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854129531 CMS
Janssen Pharmaceuticals, Inc $14.3506/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788855841 CMS
Novartis Pharmaceuticals Corporation $14.9906/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735301 CMS
Janssen Pharmaceuticals, Inc $14.8505/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788855845 CMS
AstraZeneca Pharmaceuticals LP $13.2505/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829908215 CMS
Novartis Pharmaceuticals Corporation $10.4705/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735299 CMS
Janssen Pharmaceuticals, Inc $20.6805/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788855847 CMS
Novartis Pharmaceuticals Corporation $10.7005/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735303 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $13.7805/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 768787578 CMS
Amgen Inc. $12.1905/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825128239 CMS
BOSTON SCIENTIFIC CORPORATION $23.8104/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 777712847 CMS
Bayer HealthCare Pharmaceuticals Inc. $11.7704/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789094563 CMS
Amgen Inc. $20.7704/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825128235 CMS
AstraZeneca Pharmaceuticals LP $12.9304/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829602491 CMS
iRhythm Technologies, Inc. $22.6504/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 831028769 CMS
Janssen Pharmaceuticals, Inc $17.7604/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788855843 CMS
Bayer HealthCare Pharmaceuticals Inc. $14.2804/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789123063 CMS
Novartis Pharmaceuticals Corporation $12.7603/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735297 CMS
Medtronic, Inc. $12.6603/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815718997 CMS
Amgen Inc. $18.0003/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825128231 CMS
Alnylam Pharmaceuticals Inc. $14.2103/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 828529239 CMS
Esperion Therapeutics, Inc. $13.8603/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838321817 CMS
Novartis Pharmaceuticals Corporation $19.2103/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735295 CMS
Janssen Pharmaceuticals, Inc $11.2502/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788855851 CMS
Amgen Inc. $11.8702/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825128227 CMS
Novartis Pharmaceuticals Corporation $10.6402/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735291 CMS
Novartis Pharmaceuticals Corporation $12.5201/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812735293 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $559.09 41
PY2020 $448.72 36
PY2021 $570.20 38
PY2022 $625.57 30
PY2023 $1,200.24 49
PY2024 $830.59 35
PY2025 $831.80 31

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $24,416.95 19
PY2022 Principal investigator $89,144.80 16
PY2021 Principal investigator $140,262.94 64
PY2020 Recipient $20,304.24 16
PY2020 Principal investigator $97,368.42 58
PY2019 Recipient $20,304.24 16
PY2019 Principal investigator $57,349.01 39

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

74 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $400.00 12/22/2020 Non-covered Recipient Entity
Columbus Regional Research Institute
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) No dispute reported 06/30/2026 713697695
Principal investigator 1 ARRAY BIOPHARMA INC $750.00 12/11/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742896257
Principal investigator 1 ARRAY BIOPHARMA INC $6,000.00 12/11/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742896261
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $2,187.50 11/19/2020 Non-covered Recipient Entity
Columbus Regional Research Institute
Multicenter randomized placebo controlled double-blind parallel group dose-finding Phase 2 study to evaluate the efficacy and safety of BAY 2433334 in patients following an acute myocardial infarction No dispute reported 06/30/2026 713696977
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $5,400.00 11/19/2020 Non-covered Recipient Entity
Columbus Regional Research Institute
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) No dispute reported 06/30/2026 713697001
Principal investigator 1 ARRAY BIOPHARMA INC $156.00 11/11/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742895791
Principal investigator 1 ARRAY BIOPHARMA INC $110.00 11/11/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742896253
Principal investigator 1 ARRAY BIOPHARMA INC $75.00 11/11/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742896313
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $8,750.00 10/20/2020 Non-covered Recipient Entity
Columbus Regional Research Institute
A multicenter randomized double-blind parallel-group placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction = 40% (LVEF = 40%) No dispute reported 06/30/2026 713694365
Principal investigator 1 Vifor (International) Ltd. $156.00 10/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506849
Principal investigator 1 Vifor (International) Ltd. $50.00 10/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506851
Recipient Vifor (International) Ltd. $21.00 10/16/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382491
Recipient Vifor (International) Ltd. $21.00 10/15/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382489
Recipient Vifor (International) Ltd. $21.00 10/14/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382487
Recipient Vifor (International) Ltd. $5,000.00 10/13/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382485
Recipient Vifor (International) Ltd. $800.00 10/12/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382483
Recipient Vifor (International) Ltd. $750.00 10/11/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382481
Recipient Vifor (International) Ltd. $50.00 10/10/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382479
Recipient Vifor (International) Ltd. $1,200.00 10/08/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382475
Recipient Vifor (International) Ltd. $300.00 10/07/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382473
Recipient Vifor (International) Ltd. $1,500.00 10/06/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382471
Recipient Vifor (International) Ltd. $2,925.10 10/05/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382469
Recipient Vifor (International) Ltd. $1,197.76 10/04/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382467
Recipient Vifor (International) Ltd. $1,197.76 10/03/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382465
Recipient Vifor (International) Ltd. $1,197.76 10/02/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382463
Recipient Vifor (International) Ltd. $2,925.10 10/01/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382461
Recipient Vifor (International) Ltd. $1,197.76 09/30/2020 Covered Recipient Physician DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750382459
Principal investigator 1 Amgen Inc. $5,589.00 09/22/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE
GALACTIC - HF No dispute reported 06/30/2026 731631207
Principal investigator 1 Vifor (International) Ltd. $4,000.00 09/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506847
Principal investigator 1 Vifor (International) Ltd. $2,925.10 09/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506875
Principal investigator 1 Vifor (International) Ltd. $2,925.10 09/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506877
Principal investigator 1 Vifor (International) Ltd. $2,925.10 09/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506879
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $25.90 07/21/2020 Non-covered Recipient Entity
Columbus Regional Research Institute
Multicenter randomized placebo controlled double-blind parallel group dose-finding Phase 2 study to evaluate the efficacy and safety of BAY 2433334 in patients following an acute myocardial infarction No dispute reported 06/30/2026 713689691
Principal investigator 1 Vifor (International) Ltd. $156.00 07/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506839
Principal investigator 1 Vifor (International) Ltd. $80.00 07/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506841
Principal investigator 1 Vifor (International) Ltd. $156.00 07/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506843
Principal investigator 1 Vifor (International) Ltd. $100.00 07/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506845
Principal investigator 1 ARRAY BIOPHARMA INC $370.00 07/15/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742936843
Principal investigator 1 Amgen Inc. $970.40 07/09/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE
GALACTIC - HF No dispute reported 06/30/2026 731631211
Principal investigator 1 Vifor (International) Ltd. $28.00 06/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506869
Principal investigator 1 Vifor (International) Ltd. $28.00 06/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506871
Principal investigator 1 Amgen Inc. $656.00 05/21/2020 Non-covered Recipient Entity
COLUMBUS CARDIOLOGY RESEARCH
GALACTIC - HF No dispute reported 06/30/2026 731631177
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $3,350.00 05/21/2020 Non-covered Recipient Entity
Columbus Regional Research Institute
Multicenter randomized placebo controlled double-blind parallel group dose-finding Phase 2 study to evaluate the efficacy and safety of BAY 2433334 in patients following an acute myocardial infarction No dispute reported 06/30/2026 713688041
Principal investigator 1 Bayer HealthCare Pharmaceuticals Inc. $6,562.50 05/19/2020 Non-covered Recipient Entity
Columbus Regional Research Institute
Multicenter randomized placebo controlled double-blind parallel group dose-finding Phase 2 study to evaluate the efficacy and safety of BAY 2433334 in patients following an acute myocardial infarction No dispute reported 06/30/2026 713688019
Principal investigator 1 ARRAY BIOPHARMA INC $21.00 04/03/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742936841
Principal investigator 1 ARRAY BIOPHARMA INC $21.00 04/03/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742936861
Principal investigator 1 ARRAY BIOPHARMA INC $21.00 04/03/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742936867
Principal investigator 1 ARRAY BIOPHARMA INC $21.00 04/03/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742939489
Principal investigator 1 Vifor (International) Ltd. $856.81 03/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506835
Principal investigator 1 Vifor (International) Ltd. $1,546.24 03/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506837
Principal investigator 1 Amgen Inc. $242.56 03/16/2020 Non-covered Recipient Entity
COLUMBUS CARDIOLOGY RESEARCH
GALACTIC - HF No dispute reported 06/30/2026 731631183
Principal investigator 1 ARRAY BIOPHARMA INC $185.00 03/11/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH
A PHASE 3 MULTINATIONAL RANDOMIZED PLACEBOCONTROLLED STUDY OF ARRY371797 IN PATIENTS WITH SYMPTOMATIC GENETIC DILATED CARDIOMYOPATHY DUE TO A LAMIN AC GENE MUTATION No dispute reported 06/30/2026 742936865
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506817
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506819
Principal investigator 1 Vifor (International) Ltd. $1,429.62 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506821
Principal investigator 1 Vifor (International) Ltd. $1,429.62 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506823
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506825
Principal investigator 1 Vifor (International) Ltd. $1,546.24 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506827
Principal investigator 1 Vifor (International) Ltd. $1,162.08 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506829
Principal investigator 1 Vifor (International) Ltd. $952.85 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506831
Principal investigator 1 Vifor (International) Ltd. $1,162.08 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506833
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506853
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506855
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506857
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506859
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506861
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506863
Principal investigator 1 Vifor (International) Ltd. $1,197.76 02/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506865
Principal investigator 1 Amgen Inc. $12,788.00 01/31/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE
GALACTIC - HF No dispute reported 06/30/2026 731631215
Principal investigator 1 Vifor (International) Ltd. $50.00 01/20/2020 Non-covered Recipient Entity
COLUMBUS REGIONAL RESEARCH INSTITUTE LLC
DIAMOND PAT-CR-302 No dispute reported 06/30/2026 750506867
Principal investigator 1 Merck Sharp & Dohme Corporation $62.00 01/15/2020 Non-covered Recipient Entity
COLUMBUS CARDIOLOGY ASSOCIATES RESEARCH
A randomized parallel-group, placebo-controlled, double-blind, event-driven, multi-center pivotal phase III clinical outcome trial of efficacy and safety of the oral sGC stimulator Vericiguat in subjects with heart failure and reduced ejection fraction HFrEF - VerICiguaT glObal study in subjects with heart failure and Reduced ejectIon frAction VICTORIA No dispute reported 06/30/2026 740711393
Principal investigator 1 Merck Sharp & Dohme Corporation $4,100.00 01/10/2020 Non-covered Recipient Entity
COLUMBUS CARDIOLOGY ASSOCIATES RESEARCH
A randomized parallel-group, placebo-controlled, double-blind, event-driven, multi-center pivotal phase III clinical outcome trial of efficacy and safety of the oral sGC stimulator Vericiguat in subjects with heart failure and reduced ejection fraction HFrEF - VerICiguaT glObal study in subjects with heart failure and Reduced ejectIon frAction VICTORIA No dispute reported 06/30/2026 740711391
Principal investigator 1 Merck Sharp & Dohme Corporation $2,500.00 01/10/2020 Non-covered Recipient Entity
COLUMBUS CARDIOLOGY ASSOCIATES RESEARCH
A randomized parallel-group, placebo-controlled, double-blind, event-driven, multi-center pivotal phase III clinical outcome trial of efficacy and safety of the oral sGC stimulator Vericiguat in subjects with heart failure and reduced ejection fraction HFrEF - VerICiguaT glObal study in subjects with heart failure and Reduced ejectIon frAction VICTORIA No dispute reported 06/30/2026 740711395
Principal investigator 1 Amgen Inc. $412.12 01/09/2020 Non-covered Recipient Entity
COLUMBUS CARDIOLOGY RESEARCH
GALACTIC - HF No dispute reported 06/30/2026 731631187